Details for 2016826865

Up to date per 03.04.2026

Actions

Title / Product Name

GEPUFFERTE FORMULIERUNGEN VON BEVACIZUMAB

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016826865

EP Publication Number

3397281

E-Number

1310733

Language

PCT Number

US16068847

Publication Date

07.11.2018 A

09.09.2020 B1

Registration Date

09.09.2020

AT Publication Date

15.09.2020

Application Date

28.12.2016

Registration Number

Priorities

29.12.2015

201562272116 P

IPC

A61K 39/395 20060101AFI20200505BHEP

Maximum Duration of Protection

28.12.2036

Owner

Outlook Therapeutics, Inc.7 Clarke Drive Cranbury, NJ 08512US

Representative

No representatives present

Inventor

TADDEI, Maria7 Clarke Drive Cranbury New Jersey 08512US

CHEUNG, Jessica7 Clarke Drive Cranbury New Jersey 08512US

GUTKA, Hiten7 Clarke Drive Cranbury New Jersey 08512US